Levy Richard S

Director at MDGL; EVP, Chief Drug Dev Officer at INCY

Sold, on record
$70.7M
Dollars the filings state
Form 4 sales
39
Latest May 22, 2026
Form 144 notices
1
Proposed sales
Companies
2
Filed as an executive or holder

Companies

  • MDGLMADRIGAL PHARMACEUTICALS, INC.Director
  • INCYINCYTE CORPEVP, Chief Drug Dev Officer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale INCYPlan not stated
    Jan 6 2016

    Sold 3,937 shares at $101.86 ($401k)

    Levy Richard S, EVP, Chief Drug Dev Officer

    Sold 18.9% of holdings ($2.1M position)16,926 shares left0.5x usual sizeFiling

  2. 2 Form 4 sale MDGLUnusual
    Jan 17 +2568 days

    Sold 22,489 shares at $293.15 ($6.6M)

    Levy Richard S, Director

    Sold 71.2% of holdings ($9.3M position)9,100 shares leftFirst sale on recordFiling

  3. 3 Form 144 notice MDGLNotice
    Apr 1 +440 days

    Filed to sell 11,000 shares ($2.9M)

    Levy Richard S, Director

    10b5-1 planFiling

  4. 4 Form 4 sale MDGLRoutine
    Apr 1 same day

    Sold 11,000 shares at $257.48 ($2.8M)

    Levy Richard S, Director

    10b5-1 planSold 51.6% of holdings ($5.5M position)10,298 shares leftFollows a Form 144Filing

  5. 5 Form 4 sale MDGLRoutine
    Nov 1 +214 days

    Sold 5,000 shares at $300.94 ($1.5M)

    Levy Richard S, Director

    10b5-1 planSold 31.2% of holdings ($4.8M position)11,012 shares leftFiling

  6. 6 Form 4 sale MDGLRoutine
    Nov 7 +6 days

    Sold 5,000 shares at $350.00 ($1.8M)

    Levy Richard S, Director

    10b5-1 planSold 31.2% of holdings ($5.6M position)11,012 shares left0.5x usual sizeFiling

  7. 7 Form 4 sale MDGLRoutine
    Nov 13 +371 days

    Sold 8,500 shares at $520.96 ($4.4M)

    Levy Richard S, Director

    10b5-1 planSold 28.6% of holdings ($15.5M position)21,197 shares left1.7x usual sizeFiling

  8. 8 Form 4 sale MDGLRoutine
    May 22 +190 days

    Sold 5,682 shares at $515.44 ($2.9M)

    Levy Richard S, Director

    10b5-1 planSold 20.5% of holdings ($14.3M position)22,015 shares left1.1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (40)

Form 144 notices and Form 4 sales by Levy Richard S
Source
May 22, 2026MDGLDirectorForm 4 sale5,682$2.9M20.5%RoutineSEC
Nov 13, 2025MDGLDirectorForm 4 sale8,500$4.4M28.6%RoutineSEC
Nov 7, 2024MDGLDirectorForm 4 sale5,000$1.8M31.2%RoutineSEC
Nov 1, 2024MDGLDirectorForm 4 sale5,000$1.5M31.2%RoutineSEC
Apr 1, 2024MDGLDirectorForm 4 sale11,000$2.8M51.6%RoutineSEC
Apr 1, 2024MDGLDirectorForm 144 notice11,000$2.9MNoticeSEC
Jan 17, 2023MDGLDirectorForm 4 sale22,489$6.6M71.2%UnusualSEC
Jan 6, 2016INCYEVP, Chief Drug Dev OfficerForm 4 sale3,937$401k18.9%Plan not statedSEC
Dec 7, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,937$418k18.9%Plan not statedSEC
Nov 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,936$459k18.9%Plan not statedSEC
Oct 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,937$481k18.9%Plan not statedSEC
Sep 11, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale4,301$559k20.3%Plan not statedSEC
Sep 8, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,937$468k15.6%Plan not statedSEC
Aug 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,936$441k15.6%Plan not statedSEC
Jul 15, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale70,217$8.4M76.8%UnusualSEC
Jul 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,937$421k15.6%Plan not statedSEC
Jun 19, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale20,000$2.2M48.5%UnusualSEC
Jun 8, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale3,937$424k15.6%Plan not statedSEC
May 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale7,412$737k25.9%UnusualSEC
Apr 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale25,000$2.2M54.1%UnusualSEC
Mar 6, 2015INCYEVP, Chief Drug Dev OfficerForm 4 sale25,000$2.2M54.1%UnusualSEC
Feb 17, 2015INCYEVP, Chief Drug Dev&Medical OfForm 4 sale12,000$923k39.7%UnusualSEC
Feb 6, 2015INCYEVP, Chief Drug Dev&Medical OfForm 4 sale25,000$1.9M57.9%UnusualSEC
Jan 16, 2015INCYEVP, Chief Drug Dev&Medical OfForm 4 sale12,000$877k39.7%UnusualSEC
Jan 6, 2015INCYEVP, Chief Drug Dev&Medical OfForm 4 sale25,000$1.8M57.9%UnusualSEC
Dec 16, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale12,000$868k39.7%UnusualSEC
Nov 17, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale12,000$840k39.7%UnusualSEC
Oct 16, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale8,000$392k65.0%UnusualSEC
Sep 16, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale8,000$381k65.0%UnusualSEC
Aug 18, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale8,000$416k65.0%UnusualSEC
Jul 16, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale8,000$385k65.0%UnusualSEC
Jun 16, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale8,000$431k65.0%UnusualSEC
May 16, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale8,000$405k65.0%UnusualSEC
Feb 14, 2014INCYEVP, Chief Drug Dev&Medical OfForm 4 sale231,096$15.3M98.2%UnusualSEC
Sep 6, 2013INCYEVP, Chief Drug Dev&Medical OfForm 4 sale25,000$882k100.0%UnusualSEC
May 13, 2013INCYEVP, Chief Drug Dev&Medical OfForm 4 sale55,699$1.2M92.8%UnusualSEC
Feb 15, 2013INCYEVP, Chief Drug Dev&Medical OfForm 4 sale98,440$2.2M100.0%UnusualSEC
Apr 27, 2012INCYEVP, Chief Drug Dev&Medical OfForm 4 sale30,000$689k100.0%UnusualSEC
Jan 18, 2011INCYEVP, Chief Drug Dev&Medical OfForm 4 sale40,310$637k100.0%UnusualSEC
Mar 15, 2010INCYEVP, Chief Drug Dev&Medical OfForm 4 sale20,000$259k100.0%UnusualSEC